Clinical trial Recruiting at 7 sites Interventional Ages 18 and up

Observational study on the MOVE®-C cervical disc prosthesis

Official title: "PMCF MOVE®-C" International, Prospective, Multicentre, Non-randomised Post-market Clinical Follow-up Study Clinical and Radiological Outcome After Mono- and Bisegmental Cervical Intervertebral Disc Prosthetics

Run by NGMedical GmbH · NCT05035693 · Data updated 2026-11-12

This study is testing how well the MOVE®-C cervical disc prosthesis works and if it can improve the quality of life and movement for patients with neck disc problems who haven't found relief from other treatments.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment170 (estimated)
SponsorNGMedical GmbH
Industry-sponsored
Locations7 sites (Vienna and 6 other locations)
StatusRecruiting
StartedMarch 11, 2021
Main results expectedMarch 11, 2025
Study endsMarch 11, 2027
Registry record updatedNovember 15, 2024
Trial IDNCT05035693 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with diagnosed discopathy or herniated cervical discs accompanied by radiculopathy or stenosis.

Probably not a fit

Patients with known contraindications to cervical intervertebral disc prostheses or those who have had recent surgical treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This international, prospective, multicentre, non-randomised, observational study aims to confirm the safety and performance of the MOVE®-C cervical disc prosthesis. It will collect post-market data to assess the quality of life improvements and the range of motion in patients after implantation. The study will involve patients diagnosed with discopathy or herniated cervical discs who have not responded to conservative treatment. Data will be gathered to evaluate the effectiveness of this motion-preserving implant.

Why it matters

Potential benefit: If successful, this study could enhance treatment options for patients suffering from cervical disc issues by providing a safer and more effective prosthesis.

How similar studies have gone: Other studies on cervical disc prostheses have shown promising results, indicating that this approach is supported by prior successful outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosis of discopathy or disc hernia with radiculopathy or stenosis of the foramen and spinal canal,
2. documented individual history of neck and/or upper extremity pain and/or functional/neurological deficit associated with the cervical level to be treated,
3. no surgical treatment regarding the planned index surgery within the last six weeks prior implantation,
4. unsuccessful conservative medical care regarding the indication within the last six weeks,
5. age ≥18 years,
6. patient must agree to fully participate in the clinical trial and give informed consent in writing,
7. patient is capable to realise the nature, aims and possible consequences of the clinical trial (MPG §20.2.1),
8. patient information has been provided and all written consents of the patient are available.

Exclusion Criteria:

* Known contraindication against the use of cervical intervertebral disc prostheses in accordance with the manufacturer's instructions for use:

  1. Bone mineral density with T-score ≤ -1.5 as determined by spine DXA if male ≥ 60 years of age or female ≥ 50 years of age,
  2. active systemic infection or infection at the operative site,
  3. sustained osteoporotic fracture of the spine, hip or wrist,
  4. spinal metastases,
  5. known allergy to titanium or polycarbonate-urethane,
  6. confirmed pregnancy,
  7. severe cervical myelopathy,
  8. patients requiring a treatment that destabilises the spine (e.g. posterior element decompression),
  9. advanced cervical anatomical deformity at the operative site (e.g. ankylosing spondylitis, scoliosis),
  10. advanced degenerative changes (e.g. spondylosis) at the index vertebral level,
  11. patient is kept in an institution under judicial or official orders (MPG §20.3).

Where it's running

  • Wiener Gesundheitsverbund-Klinik Penzing
    Vienna, Austria
    Recruiting
  • DRK Klinikum Berlin
    Berlin, Germany
    Recruiting
  • Wirbelsäulenzentrum Fulda Main, Kinzig
    Gelnhausen, Germany
    Recruiting
  • Medizinisches Versorgungszentrum Steinburg
    Itzehoe, Germany
    Recruiting
  • Katholisches Klinikum Koblenz - Montabaur
    Koblenz, Germany
    Recruiting
  • Neurochirurgie am Gasteig
    München, Germany
    Recruiting
Show 1 more location
  • Rhein-Maas Klinikum Würselen
    Würselen, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.